Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Mitchell Jenkins' research focuses on improving patient outcomes through evidence-based medical practices and stewardship. His work has investigated the impact of vancomycin use in academic medical centers, exploring strategies to optimize its application and reduce its utilization while maintaining patient safety. Jenkins has also examined the clinical outcomes of patients with multiple myeloma, specifically looking at the effects of viral infections like influenza and human rhinovirus on morbidity and mortality. His research in this area includes comparing outcomes between vaccinated and unvaccinated patient cohorts. Jenkins collaborates with researchers at the University of Arkansas for Medical Sciences on these studies.
Metrics
- Publications: 4
Selected Publications
-
1791. Leveraging EMR Alerts for Vancomycin Time Outs (2022)
-
1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center (2022)
-
17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated (2021)
-
1327. Human Rhinovirus Infection in Multiple Myeloma Patients: Effect on Morbidity and Mortality (2021)
Collaboration Network
Top Collaborators
- 1327. Human Rhinovirus Infection in Multiple Myeloma Patients: Effect on Morbidity and Mortality
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- 1327. Human Rhinovirus Infection in Multiple Myeloma Patients: Effect on Morbidity and Mortality
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- 1327. Human Rhinovirus Infection in Multiple Myeloma Patients: Effect on Morbidity and Mortality
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 17. A Retrospective Cohort Study of Influenza Infected Multiple Myeloma Patients Comparing Clinical Outcomes Between Vaccinated and Unvaccinated
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
Similar Researchers
Based on overlapping research topics